Open AccessReal-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
Author(s) -
Bushra Mushtaq,
Ajay S. Bhatnagar,
Helen Palmer
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s283561
Subject(s) - medicine , fluocinolone acetonide , diabetic macular edema , ophthalmology , diabetic retinopathy , intraocular pressure , visual acuity , implant , tolerability , macular edema , diabetes mellitus , surgery , adverse effect , endocrinology
To investigate real-world effectiveness and safety of fluocinolone acetonide (FAc) implant over three years of treatment in eyes with diabetic macular edema (DME) in a population with large ethnic diversity.